Data & APIsEventsMarketfyPremarketBoost
Contribute Login Join
Data & APIs
Events
Marketfy
Premarket
Boost

Andrew Blight Net Worth & Insider Trades

Andrew Blight - Chief Scientific Officer, Acorda Therapeutics Inc

As of March 3, 2017

What is Andrew Blight's Net Worth?

The current estimated net worth of Acorda Therapeutics Inc's Chief Scientific Officer, Andrew Blight, is estimated to be about $10.73M . Andrew Blight owns about 76,558 units of Acorda Therapeutics Inc common stock. In the last 11 years at Acorda Therapeutics Inc, Andrew Blight has sold an estimated value of $10.12M worth.

What is Andrew Blight's Past Insider Trading?

Andrew Blight's largest purchase order was 67,586 units , worth over $1.5M on February 13, 2017. Andrew Blight's largest sale order was 52,338 units , worth over $1.68M on October 22, 2014. In total, Andrew Blight has made about 56 transactions over 11 years of their time at Acorda Therapeutics Inc. Andrew Blight usually trades in March, with the busiest year in 2008.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Andrew Blight

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...

InsideArbitrage

Our partner InsideArbitrage provides a full suite of tools and analysis that allows you to find opportunities from the hundreds of insiders transactions filed by company insiders each week. The service includes the popular Insider Weekends articles that highlight the top 5 insider purchases and sales each week as well as detailed analysis of one company each week. The service also includes several custom screens such as the Double Dipper that includes a list of companies that are buying back their shares while their insiders are independently buying stock on the open market for their own portfolios.

What is Andrew Blight's' Mailing Address?

  • Mailing address is C/o Acorda Therapeutics, Inc. 420 Saw Mill River Road Ardsley NY 10502 NY

What are Acorda Therapeutics Inc's Past Insider Trades?

Acorda Therapeutics Inc's most recent insider trade came on March 20, 2023 by Ron Cohen who bought 20,156 units worth $12.59K . In the last 17 years, insiders at Acorda Therapeutics Inc have sold an estimated value of $209.22M and bought an estimated value of $39.66M worth of shares. Insider trading is most common in June, with the busiest year in 2018. The most active traders at the company are David Lawrence, Chief,  Ron Cohen, President and CEO,  and Jane Wasman, President .

Acorda Therapeutics, Inc. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...